Moreover, novel HO-1 inhibition tools were reported such as arylethanolimidazole derivatives in cancer [49], caffeic acid phenethyl ester in diabetes [50] and fumarate hydratase as target genes in cancer [51]. This evidence concerns the gene FH and diabetes mellitus.